The overall objective of this contract is to advance the development of the biofire emerging COV panel as a nucleic acid amplification test panel for use on the easy-to-use filmarray 2.0 and filmarray…
Active Definitive Contract Awarded Last action
- Contract number
- 75A50122C00073
- Awardee
-
Biofire Defense LLC UEI NHMDGM122546
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $15,958,896
Award facts
- Opportunity
-
- Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) Pre-Solicitation · BAA18100SOL00003 · Posted Oct 16, 2017
- Contract value 100% obligated
- $15,958,895.53 Current and potential, with all options
- Completion date 78% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Millcreek, UT 84107, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $3,242,588 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $12,716,307 |
About this award
This is a $15,958,895.53 cost-plus-fixed-fee contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Biofire Defense LLC, a for-profit limited liability company based in Salt Lake City, Utah. The contract is to advance the development of the Biofire Emerging COV Panel, a nucleic acid amplification test panel for use on the Biofire FilmArray 2.0 and FilmArray Torch molecular diagnostic platforms. This contract aligns with ASPR's mission to support the development of medical countermeasures, including diagnostics, to address chemical, biological, radiological, and nuclear threats as well as pandemic influenza. Biofire Defense has a strong track record of federal contract awards and grants for providing specialized diagnostic solutions to government agencies. The original solicitation was a Broad Agency Announcement from BARDA seeking proposals for the advanced research and development of medical countermeasures. This contract does not utilize a set-aside designation.
Description
The overall objective of this contract is to advance the development of the biofire emerging COV panel as a nucleic acid amplification test panel for use on the easy-to-use filmarray 2.0 and filmarray torch platforms.
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| University Of Texas Medical Branch At Galveston | $225,389 | |
| The Tampa General Hospital Foundation Inc | $177,546 | |
| Wake Forest University Health Sciences | $130,162 | |
| Emory University | $232,825 | |
| George Washington University (The) | $163,850 | |
| Children's Hospital LOS Angeles | $159,453 | |
| Emory University | $121,192 | |
| Children's Hospital LOS Angeles | $75,053 | |
| George Washington University (The) | $89,255 |
Quick answers
Who was awarded contract 75A50122C00073?
75A50122C00073 was awarded to Biofire Defense LLC by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 30, 2022.
How much is contract 75A50122C00073 worth?
The government has obligated $15,958,896 on 75A50122C00073.
Was contract 75A50122C00073 competed?
The extent of competition for 75A50122C00073 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award